RA Capital Management, L.P. 13D/13G Filings for Regulus Therapeutics Inc. (RGLS)

RA Capital Management, L.P. 13D and 13G filings for Regulus Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
5:46 pm
Purchase
2024-09-3013GRegulus Therapeutics Inc.
RGLS
RA Capital Management, L.P.766,834
1.200%
766,834increase
(New Position)
Filing